(Published in Part II, Section 3, Sub-section (ii) of

the Gazette of India, Extraordinary, dated the 30^th November, 2007)

Government of India

Ministry of Chemicals and Fertilizers

National Pharmaceutical Pricing Authority

New Delhi, the 30^th November, 2007

ORDER

 

S.O. 2061(E)- In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4^th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (5) of the Table hereto annexed as the retail price/revised retail price, exclusive of excise duty, sales taxes/VAT and local taxes, if any, and in column (6) equivalent MRP inclusive of excise duty, education cess, sales tax / VAT in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Pfizer Products India Pvt. Ltd.

TABLE

Sl. No.	Name of the formulation	Strength	Pack   Size	Ceiling Price (Rs.)	Equivalent MRP*  inclusive  of all taxes  (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Depo Medrol 40mg injection  Each ml contains    Methyl Prednisolone Acetate 40 mg Batch no – PO5554  Qty. – 123097	1ml  Vial	90.62	48.69	50.64
2	Depo Medrol 40mg injection Each ml contains Methyl Prednisolone Acetate 40 mg Batch no – PO5559  Qty. 120558	2ml Vial	90.62	72.35	75.24
3	Solu Medrol AOV 40mg injection  Each ml contains Methyl Prednisolone Sodium Succinate  40 mg Batch no – PO5079 Qty.  – 45926	1ml   Vial	150.96	139.71	145.30
4	Solu Medrol AOV 500mg injection Each ml contains Methyl Prednisolone Sodium Succinate  500 mg Batch no – OADJX Qty.  – 21724	4ml  Vial	696.81	615.23	639.84
5	Solu Medrol AOV 1000mg injection  Each ml contains  Methyl Prednisolone Sodium Succinate  1000 mg  Batch no – OABT5 Qty.  – 33819	8ml  Vial	1134.00	917.25	953.96
6	Solu Medrol 125mg injection Each ml contains    Methyl Prednisolone Sodium Succinate  125 mg Batch no – PO5962  Qty.  – 40080	2ml  Vial	287.04	253.80	263.95
7	Medrol 4mg Tablet Methyl Prednisolone 4 mg  Batch no – F429A Qty.  – 14544	10×10’s Strip/Blister	384.57	323.63	336.57
8	Medrol 4mg Tablet Methyl Prednisolone 4 mg  Batch no – F570A Qty.  – 17472	10×10’s Strip/Blister	384.57	323.63	336.57
9	Medrol 16mg Tablet  Methyl Prednisolone 16 mg Batch no – F220B Qty.  – 12204	14’s  Strip/Blister	168.90	143.40	149.14
10	Medrol 4mg Tablet Methyl Prednisolone 4 mg Batch no – 60166/A  Qty.  – 7296	10×10’s  Strip/Blister	384.57	325.77	338.80
11	Medrol 4mg Tablet    Methyl Prednisolone 4 mg   Batch no – F429A Qty.  – 14784	10×10’s  Strip/Blister	384.57	324.59	337.57

*Subject to actual payment of Government levies/taxes, as applicable.

Note :

(a)        The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b)        The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5).  If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.

(c)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

(d)        The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing /marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.

(e)        These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

(f)         The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.

PN/97/2007/F

F. No. 8(7)/2007/D.P./NPPA-Div.-II

                                                                                                              (RAJIV WADHAWAN)

                                                                                                                     Deputy Director